These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 30327362)
41. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes. Kekäläinen P; Juuti M; Walle T; Laatikainen T Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287 [TBL] [Abstract][Full Text] [Related]
42. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. Saudek CD; Duckworth WC; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA JAMA; 1996 Oct 23-30; 276(16):1322-7. PubMed ID: 8861991 [TBL] [Abstract][Full Text] [Related]
43. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes. Meek CL; Tundidor D; Feig DS; Yamamoto JM; Scott EM; Ma DD; Halperin JA; Murphy HR; Corcoy R; Diabetes Care; 2021 Mar; 44(3):681-689. PubMed ID: 33495292 [TBL] [Abstract][Full Text] [Related]
44. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus. Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316 [TBL] [Abstract][Full Text] [Related]
45. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures. Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892 [TBL] [Abstract][Full Text] [Related]
46. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study. Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264 [TBL] [Abstract][Full Text] [Related]
47. Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization. Parkin CG; Graham C; Smolskis J J Diabetes Sci Technol; 2017 May; 11(3):522-528. PubMed ID: 28745091 [TBL] [Abstract][Full Text] [Related]
48. Continuous glucose monitoring in pregnant women with Type 1 diabetes: benefits for mothers, using pumps or pens, and their babies. Feig DS; Murphy HR Diabet Med; 2018 Apr; 35(4):430-435. PubMed ID: 29352491 [TBL] [Abstract][Full Text] [Related]
49. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ; Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759 [TBL] [Abstract][Full Text] [Related]
50. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes. Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413 [TBL] [Abstract][Full Text] [Related]
51. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454 [TBL] [Abstract][Full Text] [Related]
52. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007 [TBL] [Abstract][Full Text] [Related]
53. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O; Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123 [TBL] [Abstract][Full Text] [Related]
54. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889 [TBL] [Abstract][Full Text] [Related]
55. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes. Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211 [TBL] [Abstract][Full Text] [Related]
57. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment. Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243 [TBL] [Abstract][Full Text] [Related]
58. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population. Bratke H; Margeirsdottir HD; Assmus J; Njølstad PR; Skrivarhaug T Diabetes Ther; 2021 Sep; 12(9):2571-2583. PubMed ID: 34389930 [TBL] [Abstract][Full Text] [Related]
59. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study. Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735 [TBL] [Abstract][Full Text] [Related]
60. Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial. Little SA; Speight J; Leelarathna L; Walkinshaw E; Tan HK; Bowes A; Lubina-Solomon A; Chadwick TJ; Stocken DD; Brennand C; Marshall SM; Wood R; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JAM Diabetes Care; 2018 Aug; 41(8):1600-1607. PubMed ID: 29661916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]